CLINICAL_TRIALS
research
· 2017-07-17
Clinical Trial Update: Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 trial evaluating Cinobufacini tablets in combination with standard chemotherapy for diffuse large B-cell lymphoma; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xinjiang Medical University | Conditions: Diffuse, Large B-Cell, Lymphoma | Phase 2, Phase 3 | Status: UNKNOWN